Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells by WNT Switch Method

doi:10.3390/cells13020132

Isaiah K. Mensah, Martin L. Emerson, Hern J. Tan, Humaira Gowher

Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells by WNT Switch Method

General Medicine

The differentiation of ESCs into cardiomyocytes in vitro is an excellent and reliable model system for studying normal cardiomyocyte development in mammals, modeling cardiac diseases, and for use in drug screening. Mouse ESC differentiation still provides relevant biological information about cardiac development. However, the current methods for efficiently differentiating ESCs into cardiomyocytes are limiting. Here, we describe the “WNT Switch” method to efficiently commit mouse ESCs into cardiomyocytes using the small molecule WNT signaling modulators CHIR99021 and XAV939 in vitro. This method significantly improves the yield of beating cardiomyocytes, reduces number of treatments, and is less laborious.

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

Web-based, modern reference management
Collaborate and share with fellow researchers
Integration with Overleaf
Comprehensive BibTeX/BibLaTeX support
Save articles and websites directly from your browser
Search for new articles from a database of tens of millions of references

Try out CiteDrive

Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells by WNT Switch Method

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

More from our Archive

Virtual education strategies in the context of sustainable health care and medical education: A topic modelling analysis of four decades of research

Perinatal Depression and Risk of Suicidal Behavior

The new frontier: Clinical consequences of long COVID

The infection-tolerant white-footed deermouse tempers interferon responses to endotoxin in comparison to the mouse and rat

Hospital at Home Program for the Treatment of Pediatric Osteoarticular Infections

Xylazine in Overdose Deaths and Forensic Drug Reports in US States, 2019-2022

Feasibility and performance of in-house red blood cell reagents to detect unexpected antibodies in immunized patients in Burkina Faso

Dabrafenib and trametinib as a promising treatment option for pediatric population with low-grade gliomas that have BRAF V600E mutation; a breakthrough in the field of neuro-oncology

Exposure to Residential Green Space and Bone Mineral Density in Young Children

Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates